BINAX NOW RSV TEST KIT
INV-430-122
(22 tests)
BINAX NOW RSV TEST KIT. Respiratory Syncytial Virus (RSV) Test Kits. The NOW RSV Test is a rapid immunochromatographic assay for the qualitative detection of respiratory syncytial virus (RSV) fusion protein antigen in nasal wash and nasopharyngeal swab specimens from symptomatic patients. FDA Cleared and CLIA Waived. (FDA 510K#: K032166)
$279.00

Qty:

More Info
Product Insert
Procedure Card

BINAX NOW RSV TEST KIT
INV-430-100
(10 Tests)
BINAX NOW RSV TEST KIT. Respiratory Syncytial Virus (RSV) Test Kits. The NOW RSV Test is a rapid immunochromatographic assay for the qualitative detection of respiratory syncytial virus (RSV) fusion protein antigen in nasal wash and nasopharyngeal swab specimens from symptomatic patients. FDA Cleared and CLIA Waived. (FDA 510K#: K032166
$129.95

Qty:

More Info
Product Insert
Procedure Card

ClearView RSV Rapid Test Kit
INV-135060
(20 Tests)
Wampole Laboratories Clearview RSV Test kit. Respiratory Syncytial Virus (RSV) Test Kits, a 15 minute test for the qualitative detection of RSV. Sensitivity 93.8%; Specificity 97.7%. The Clearview RSV test includes built in control that ensures accuracy. FDA Cleared and CLIA waived. (FDA 510K#: K021789)
$245.00

Qty:

More Info
Product Insert
Test Instructions

SAS RSV Alert Testing Kit
SAS-041130
(30 Tests)
SAS RSV Alert Testing Kit. Respiratory Syncytial Virus (RSV) Test Kits, the SAS RSV antigen test is a visual and rapid assay for the presumptive qualitative detection of Respitory Syncytial(RSV) antigen directly from nasopharyngeal specimens in neonatal and pediatric patients. One step 15 minute. test. FDA Cleared and CLIA Waived. (FDA 510K#: K022845)
$309.00

Qty:

More Info
Product Insert
Test Instructions

Quidel QuickVue RSV Test Kit
QDL-20193
(20 Tests)
Respiratory Syncytial Virus (RSV) Test Kits, the QuickVue RSV test is a dipstick immunoassay which allows for the rapid, qualitative detection of respiratory syncytial virus (RSV) antigen (viral fusion protein) directly from nasopharyngeal swab or nasopharyngeal aspirate specimens for symptomatic pediatric patients (eighteen years of age and younger). The test is intended for use as an aid in the diagnosis of acute respiratory syncytial viral infections. It is recommended that negative test results be confirmed by cell culture. Negative results do not preclude RSV infection and it is recommended that they not be used as the sole basis for treatment or other management decisions. FDA Cleared and CLIA Waived. (FDA 510K#: K061008)
$299.95

Qty:

More Info
Test Instructions